1 / 53

Price & Cost Transparency: Understanding the Issues – Shaping the Agenda

Price & Cost Transparency: Understanding the Issues – Shaping the Agenda. Consumer-Purchaser Disclosure Project: Invitational Working Session May 25, 2006. Agenda. Goals, Drivers & Context Audiences for Price Information Defining Price & Cost Information Examples of Price Transparency

Download Presentation

Price & Cost Transparency: Understanding the Issues – Shaping the Agenda

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Price & Cost Transparency: Understanding the Issues – Shaping the Agenda Consumer-Purchaser Disclosure Project: Invitational Working Session May 25, 2006

  2. Agenda • Goals, Drivers & Context • Audiences for Price Information • Defining Price & Cost Information • Examples of Price Transparency • Major Issues and Questions

  3. Why New Attention to Price/Cost? • Consumer Demand • Increased cost sharing • More consumers in plans with coinsurance • Equity concerns regarding pricing for the uninsured • Private Purchaser • Inclusion of cost/price information in NCQA new health plan “Physician/Hospital Quality” Accreditation Module • Push for efficiency leading to cost alone • State Interest • Legislation mandating publication of chargemaster • Concern for equity of pricing for the uninsured • Public reporting efforts • Federal Interest • Price transparency core element of Administration Initiative • CMS Request for Comment (Fed.Reg. due 6/12/06) • House Ways & Means Hearing

  4. Goals of Price/Cost Transparency • Promote higher value – linking quality and cost • Enable consumers to make better informed choices (especially as they bear more direct out-of-pocket exposure) • Bring market forces to bear on providers to reduce costs • Encourage payment system overhaul by making transparent current dysfunction

  5. Administration Comment Request • “Any” ways HHS can encourage transparency in health care quality and pricing – voluntary or through regulatory authority • How could CMS use of its regulatory authority to enhance transparency of quality and pricing information? • Would the publication of Medicare rates be helpful or harmful? • Should CMS publish is risk-adjusted DRG rates for every hospital? • Should HHS establish conditions of participation for hospitals that require posting of prices and/or policies regarding discounts and other payment options for uninsured patients? • Should CMS publish total payments over an episode of care?

  6. Context: Who’s Doing the Spending

  7. Context: Where’s the Money Going

  8. Nonelderly Coverage

  9. Context: The Uninsured

  10. Plan Enrollment of Covered Workers Source: Kaiser/HRET 2005 Annual Employer Benefits Survey

  11. Costs in Context – Consumers in PPOs

  12. Costs in Context – Consumers in HDHPs

  13. Medicare Coverage

  14. Sources of Payment for Medicare Beneficiaries Source: Kaiser Family Foundation, Medicare Chartbook 2005

  15. Medicare Out-of-Pocket Spending Source: Kaiser Family Foundation, Medicare Chartbook 2005

  16. MedicareOut-of-Pocket Source: Kaiser Family Foundation, Medicare Chartbook 2005

  17. Medicare Out-of-Pocket for those with High Costs Source: Medicare Beneficiaries Out-of-Pocket Costs: Are Medicare Advantage Plans a Better Deal? May 2006, Commonwealth Fund

  18. Remember the Value Equation SAVE LIVES, SAVE MONEY Adapted from Regence Blue Shield

  19. Price/Cost Information Users • Consumers • Providers • Plans • Purchasers

  20. Consumers’ Circumstances • Plan/Payer Status • Health plan enrollee • Medicare FFS • Uninsured • Health Status/Condition • Procedure/Medical • Urgent/Non-urgent • Chronic • Preference Sensitive • Education/Information Seeking See Appendix for Consumer Vignettes

  21. ALL Consumers Need Price Information that is “QUAARP”: • Linked directly to Quality measures (outcomes, patient experience, compliance with EBM) • Understandable • Actionable • Accessible • Relevant to their circumstances (health and coverage status) • Predictive (accurate)

  22. Consumers’ Needs by Payer Status (“QUAARP” Plus)

  23. Consumers’ Needs by Health Status/Issue (“QUAARP” Plus)

  24. Purchasers’ Information Needs

  25. Health Plans’ Information Needs

  26. Providers’ Information Needs

  27. Consumer Care Types • Procedures: • Outpatient • Inpatient (e.g., Hip Replacement, Delivery, CABG, Disk Surgery) • Discrete Services • Preventive Screening • Tests (e.g., MRI, biopsy) • Prescription/OTC Drugs • Ongoing Chronic Care • Diabetes • Asthma • COPD • Depression • Emergent and Very Expensive – “Never-Relevant Events” • Heart Attack • So expensive – OOP irrelevant

  28. Cost/Service Categories (1 of 2) • Total Costs All Care: costs for all medical expenses attendant with ALL care received by an individual, family OR population. Issues: • Most relevant information for an employer or public purchaser • Needs effective risk adjustment for comparative purposes • Increasingly “plan chooser tools” are estimating consumers’ total costs including share or premium and all out-of-pocket • For consumer can address the unknown of future care needs • Episode of Care Costs: costs for all medical expenses attendant with a particular procedure including all professional costs, therapy, diagnostics and drugs. Issues: • Rarely available or made actionable for consumers or providers • Annual Treatment Costs: costs for all medical expenses attendant with a particular chronic condition (e.g., asthma), including all professional costs, therapy, diagnostics and drugs. Issues: • Average estimates may vary greatly • Difficult to predict actual scope of some visits

  29. Cost/Service Categories (2 of 2) • Inpatient Costs: costs of particular procedures (e.g., hip replacement). Issues: • Cost may only reflect partial elements of total costs (e.g., only those of inpatient facility, not ancillary physician costs) • Outpatient Costs: costs of typical outpatient procedures. Issues: • Costs likely to reflect facility and professional service fees, but may • Office Visit/Unit of Service: costs for “typical” office visits (e.g., physician visit, physical therapy, MRI, x-ray). Issues: • Difficult to predict actual scope of some visits • Unit of Service: costs for specific tests, services (e.g., charge master-detail). Issues: • Difficult to predict actual scope of some visits • Prescription Drug: costs of prescription drug associated with particular treatment. Issues: • Cost for what course of treatment • Whether costs compared to alternatives

  30. Cost Information Displays • Full charges (no health plan discounts) • Discounted rates (health plan discount applied) • Average costs (NOT provider specific; may be commercial, Medicare or combined) • Range of costs (NOT provider specific; may be commercial, Medicare or combined) • Provider specific costs – charges, discounted or relative • Cost to member/Out-of-pocket

  31. Sources of Price Information • Health plan • Multiple health plan • Medicare • Provider (e.g., hospital)

  32. Examples of Price Information In the Market • New Hampshire: Department of Insurance and Hospital Association • Consumers Union (Prescription Drugs) • United Health Plan • Aetna

  33. Presentations

  34. New Hampshire Price ToolsDepartment of Insurance: “NH Health Cost” @ www.nhcost.orgHospital Association: “New Hampshire PricePoint” @ www.nhpricepoint.org

  35. Sample Presentations • Consumers Union (Prescription Drugs) • United Health Plan • Aetna

  36. Major Alternatives: Strengths, Weaknesses and Recommendations • Price in Absence of Quality Information • Total Costs of Care – Population or Multi-Condition • Full charges (no plan/other discounts) • Actual plan rates • Average, relative or range of costs • Others

  37. Administration Comment Request • “Any” ways HHS can encourage transparency in health care quality and pricing – voluntary or through regulatory authority • How could CMS use of its regulatory authority to enhance transparency of quality and pricing information? • Would the publication of Medicare rates be helpful or harmful? • Should CMS publish is risk-adjusted DRG rates for every hospital? • Should HHS establish conditions of participation for hospitals that require posting of prices and/or policies regarding discounts and other payment options for uninsured patients? • Should CMS publish total payments over an episode of care?

  38. Major Outstanding Questions

  39. Price TransparencyAppendix • Consumer Vignettes • Covered Workers’ Cost-Sharing and Coinsurance • Medicare Benefits and Cost-Sharing • Consumer-Purchaser Disclosure Project Information

  40. Consumer Vignettes (1 of 2)

  41. Consumer Vignettes (2 of 2)

  42. Coinsurance for Covered Workers

  43. Cost-Sharing for Covered Workers

More Related